| scholarly article | Q13442814 |
| P50 | author | Lixin Wei | Q88547659 |
| Jie Liu | Q88552145 | ||
| Cen Li | Q89229197 | ||
| Ravikanth Velagapudi | Q92097147 | ||
| Feng Zhang | Q92804459 | ||
| Olumayokun A Olajide | Q56809856 | ||
| P2093 | author name string | Feng Zhang | |
| Jie Liu | |||
| Li-Xin Wei | |||
| Cen Li | |||
| Olumayokun A Olajide | |||
| Velagapudi Ravikanth | |||
| P2860 | cites work | Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet | Q24642468 |
| Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials? | Q24642675 | ||
| Śodhana: An Ayurvedic process for detoxification and modification of therapeutic activities of poisonous medicinal plants | Q26797428 | ||
| Anti-diabetic formulations of Nāga bhasma (lead calx): A brief review | Q26851404 | ||
| Jasada bhasma, a Zinc-Based Ayurvedic Preparation: Contemporary Evidence of Antidiabetic Activity Inspires Development of a Nanomedicine | Q27015895 | ||
| Determination of in vitro bioaccessibility of Pb, As, Cd and Hg in selected traditional Indian medicines | Q28388928 | ||
| Bioaccessibility of lead and arsenic in traditional Indian medicines | Q28394192 | ||
| Fourier transform infrared analysis of Tamra Bhasma at different levels: A preliminary study | Q28397110 | ||
| Toxicity study of Lauha Bhasma (calcined iron) in albino rats | Q28603559 | ||
| Acute and Subchronic Toxicity Study of Tamra Bhasma (Incinerated Copper) prepared from Ashodhita (Unpurified) and Shodhita (Purified) Tamra in Rats | Q28679149 | ||
| [Material Composition Research on Tibetan Medicine "Brag-zhun"] | Q86300216 | ||
| [Special aspects of quality of Tibetan medicines--insights from over 40 years of manufacturing experience in Switzerland] | Q87104071 | ||
| [An introduction of Zuotai in Tibetan patent medicine] | Q95407726 | ||
| [A powder X-ray diffractometry for detection of Tibetan medicine Zuotai] | Q95429071 | ||
| [Overview of current researches on Tibetan medicine "zuotai"] | Q95501755 | ||
| Bioavailability study of arsenic and mercury in traditional Chinese medicines (TCM) using an animal model after a single dose exposure. | Q50938780 | ||
| Comparison of mercury sulfides with mercury chloride and methylmercury on hepatic P450, phase-2 and transporter gene expression in mice. | Q51606079 | ||
| Zuotai and HgS differ from HgCl2 and methyl mercury in Hg accumulation and toxicity in weanling and aged rats. | Q51820708 | ||
| Activation of Nrf2 Pathway Contributes to Neuroprotection by the Dietary Flavonoid Tiliroside. | Q52672645 | ||
| Ayurveda formulations: A roadmap to address the safety concerns. | Q55247762 | ||
| UPLC/Q-TOFMS-Based Metabolomics Approach to Reveal the Protective Role of Other Herbs in An-Gong-Niu-Huang Wan Against the Hepatorenal Toxicity of Cinnabar and Realgar. | Q55361921 | ||
| Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills | Q79614411 | ||
| [Study on safety of Tibetan medicine zuotai and preliminary study on clinical safety of its compound dangzuo] | Q85668232 | ||
| The genetic basis for bacterial mercury methylation | Q86082339 | ||
| Ancient concept of metal pharmacology based on Ayurvedic literature | Q28730349 | ||
| Critical review on the pharmaceutical vistas of Lauha Kalpas (Iron formulations) | Q28730570 | ||
| Chemical Species, Micromorphology, and XRD Fingerprint Analysis of Tibetan Medicine Zuotai Containing Mercury | Q28822527 | ||
| Clinical study on prospective efficacy of all-trans Acid, realgar-indigo naturalis formula combined with chemotherapy as maintenance treatment of acute promyelocytic leukemia | Q33746130 | ||
| Tibetan medicine: a systematic review of the clinical research available in the west | Q34036645 | ||
| Chemical and structural analysis of Nengchi Bajin ashes in refining of Tibetan medicine gTSo thal | Q34423697 | ||
| Mercury methylation by novel microorganisms from new environments | Q34984897 | ||
| Preparation and Characterization of Suvarna Bhasma Parada Marit | Q36341544 | ||
| Ayurvedic management of life-threatening skin emergency erythroderma: A case study | Q36393565 | ||
| Pharmacovigilance study of Ayurvedic medicine in Ayurvedic Teaching Hospital: A prospective survey study | Q36667454 | ||
| Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and Arogyavardhini Vati) in dyslipidemia patients: A pilot prospective cohort clinical study | Q36726951 | ||
| Anti-diabetic activity of traditional Indian gold containing preparation: Shadguna Balijarita Makaradhwaja on streptozotocin induced diabetic rats | Q36810893 | ||
| Evidence for safety of Ayurvedic herbal, herbo-metallic and Bhasma preparations on neurobehavioral activity and oxidative stress in rats | Q36879737 | ||
| Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia | Q36949139 | ||
| Acute and subchronic toxicity study of Tamra Bhasma (incinerated copper) prepared with and without Amritikarana | Q37011125 | ||
| Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice | Q37151179 | ||
| Herbogenomics: from traditional Chinese medicine to novel therapeutics | Q37183925 | ||
| Mineral arsenicals in traditional medicines: orpiment, realgar, and arsenolite | Q37221305 | ||
| The hypolipidemic activity of Ayurvedic medicine, Arogyavardhini vati in Triton WR-1339-induced hyperlipidemic rats: A comparison with fenofibrate | Q37290138 | ||
| Effect of Ayurveda Medications (Kasīsa Bhasma and Dhātrī Avaleha) on Iron Deficiency Anaemia: A Randomized Controlled Study | Q37599254 | ||
| Bhasma : The ancient Indian nanomedicine | Q37651205 | ||
| Therapeutic potentials of metals in ancient India: A review through Charaka Samhita | Q37901372 | ||
| Mercury-based traditional herbo-metallic preparations: a toxicological perspective. | Q37996311 | ||
| Learning to program the liver | Q38155595 | ||
| Safety and toxicity issues associated with lead-based traditional herbo-metallic preparations | Q38161667 | ||
| Ayurvedic Bhasmas: overview on nanomaterialistic aspects, applications, and perspectives | Q38195240 | ||
| The role of herbometallic preparations in traditional medicine--a review on mica drug processing and pharmaceutical applications. | Q38226160 | ||
| From medical tradition to traditional medicine: A Tibetan formula in the European framework | Q38275032 | ||
| Homeopathy--between tradition and modern science: remedies as carriers of significance | Q38452464 | ||
| Plants used to treat diabetes in Sri Lankan Siddha Medicine - An ethnopharmacological review of historical and modern sources | Q38838758 | ||
| The Ayurvedic Pharmacopoeia of India, development and perspectives | Q38893785 | ||
| Development of Ayurveda - Tradition to trend. | Q38955524 | ||
| Standard manufacturing process of Makaradhwaja prepared by Swarna Patra - Varkha and Bhasma. | Q39085868 | ||
| Chemical form of metals in traditional medicines underlines potential toxicity in cell cultures | Q39597686 | ||
| Nature vs. nurture: gold perpetuates "stemness". | Q39614154 | ||
| In vitro studies on dissolved substance of cinnabar: chemical species and biological properties. | Q39684635 | ||
| Lead intoxication due to ayurvedic medications as a cause of abdominal pain in adults. | Q40427736 | ||
| Speciation and bioavailability of lead in complementary medicines. | Q40545918 | ||
| Characterization of Tarakeshwara Rasa: An Ayurvedic herbomineral formulation | Q41087973 | ||
| Physicochemical characterization and antibacterial activity of Rajata Bhasma and silver nanoparticle | Q41226553 | ||
| Comparative study on cellular entry of incinerated ancient gold particles (Swarna Bhasma) and chemically synthesized gold particles | Q41630394 | ||
| Adaptogenic potential of Oxitard in experimental chronic stress and chronic unpredictable stress induced dysfunctional homeostasis in rodents | Q41689059 | ||
| Standard manufacturing procedure of Tamra Bhasma | Q41772709 | ||
| Wound healing activity of topical application forms based on ayurveda | Q41831044 | ||
| Is mercury in Tibetan Medicine toxic? Clinical, neurocognitive and biochemical results of an initial cross-sectional study | Q42292524 | ||
| A method to evaluate hormesis in nanoparticle dose-responses | Q42321831 | ||
| Integrity of Ayurveda | Q42340027 | ||
| Effects of Lead in Various Preparatory Stages of Nagabhasma on Function and Histopathology of Cornu Ammonis of Hippocampus. | Q42363970 | ||
| AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. | Q42372546 | ||
| Safety evaluation of an Ayurvedic medicine, Arogyavardhini vati on brain, liver and kidney in rats | Q42722233 | ||
| Neurotoxicological effects of low-dose methylmercury and mercuric chloride in developing offspring mice. | Q42769233 | ||
| Yashada bhasma (Zinc calx) and Tankana (Borax) inhibit Propionibacterium acne and suppresses acne induced inflammation in vitro | Q42803702 | ||
| The chemical speciation, spatial distribution and toxicity of mercury from Tibetan medicine Zuotai，β-HgS and HgCl2 in mouse kidney | Q46254677 | ||
| Impacts of the Human Gut Microbiome on Therapeutics. | Q46285382 | ||
| Attenuation of stress-elicited brain catecholamines, serotonin and plasma corticosterone levels by calcined gold preparations used in Indian system of medicine. | Q46504375 | ||
| A survey on medicinal materials used in traditional systems of medicine in Sri Lanka | Q46879150 | ||
| Ayurveda formulations: A roadmap to address the safety concerns | Q47140677 | ||
| Study on physical properties of Ayurvedic nanocrystalline Tamra Bhasma by employing modern scientific tools. | Q47178817 | ||
| Metals and metalloids in complementary and alternative medicines | Q47196320 | ||
| Safety and bioactivity studies of Jasad Bhasma and its in-process intermediate in Swiss mice | Q47295322 | ||
| Ayurvedic bhasma: nanomedicine of ancient India--its global contemporary perspective | Q47306491 | ||
| Cinnabar is not converted into methylmercury by human intestinal bacteria | Q47315884 | ||
| The Tibetan medicine Zuotai differs from HgCl2 and MeHg in producing liver injury in mice | Q47322223 | ||
| Formulation, characterization and comparative evaluation of Trivanga bhasma: a herbo-mineral Indian traditional medicine | Q47625076 | ||
| The depressive-like behaviors of chronic unpredictable mild stress-treated mice, ameliorated by Tibetan medicine Zuotai: involvement in the hypothalamic-pituitary-adrenal (HPA) axis pathway | Q47643510 | ||
| In-house preparation and characterization of an Ayurvedic bhasma: Praval bhasma | Q47677437 | ||
| Anti-diabetic activity and safety assessment of Ayurvedic medicine, Jasada bhasma (zinc ash) in rats | Q47697853 | ||
| An experimental assessment of toxic potential of nanoparticle preparation of heavy metals in streptozotocin induced diabetes | Q47746294 | ||
| Bioaccessibility of mercury in selected Ayurvedic medicines | Q47772067 | ||
| Effect of Cys, GSH, and pH on Mercury Release from Tibetan Medicine Zuotai, β-HgS, and α-HgS in Artificial Gastrointestinal Juices. | Q47800139 | ||
| Bioaccessibility and health risk assessment of mercury in cinnabar containing Traditional Chinese Medicines | Q47862122 | ||
| Cinnabar is different from mercuric chloride in mercury absorption and influence on the brain serotonin level | Q48219147 | ||
| Differential neurotoxic effects of methylmercury and mercuric sulfide in rats | Q48276769 | ||
| Natural Medicines Used in the Traditional Tibetan Medical System for the Treatment of Liver Diseases | Q49481817 | ||
| Synthesis and characterization of Vangabhasma. | Q50134731 | ||
| A review of cinnabar (HgS) and/or realgar (As4S4)-containing traditional medicines | Q50232443 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1697804 | |
| P577 | publication date | 2019-01-10 | |
| P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
| P1476 | title | Chemical Compositions of Metals in Bhasmas and Tibetan Zuotai Are a Major Determinant of Their Therapeutic Effects and Toxicity | |
| P478 | volume | 2019 |
Search more.